Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00644280 · ClinicalTrials.gov registry record · NA
Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00644280 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 11 participants.
The verdict
NCT00644280, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
To determine whether ranibizumab therapy before and after tube insertion for glaucoma surgeries can maintain the patency of the tube and prevent scar formation, and increase the chances for a successful procedure compared to observation.
Interventions
- DRUG Ranibizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00644280
The ClinicalTrials.gov registry entry for NCT00644280 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ranibizumab is the first listed.
NCT00644280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00644280 about?
NCT00644280 is a clinical study titled "Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery". To determine whether ranibizumab therapy before and after tube insertion for glaucoma surgeries can maintain the patency of the tube and prevent scar formation, and increase the chances for a successful procedure compared to observation.
What is the current status of trial NCT00644280?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2008-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00644280?
The interventions under investigation include: Ranibizumab (DRUG).
Who is sponsoring clinical trial NCT00644280?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.